Long-term bets: What to Buy, Sell and Hold

JM Financial has retained a buy rating on Wipro citing the acquisition of Viteos, a BPaaS provider for the alternate investment manage ment industry, to be positive for the company as it gives Wipro a beach-head in the BPaaS space. The broker age said that though the acquisition is marginally EPS dilutive, financial impact is limited. The stock rose 0.03% to Rs 555.95 on Thursday.

Edelweiss Securities has initiated coverage on Natco Pharma (NATP) with a buy recommendation and target price of Rs 640. The firm an nounced it has settled the pending Revlimid litigation with Celgene, thereby ensur ing a launch in March 2022.

The brokerage said though the launch will happen later than anticipated, it brings im portant certainty to NATP's thesis and is one of the many catalysts. The stock fell 0.46% to Rs 572.7 on Thursday.

Emkay Global has main tained a buy rating on Mangalam Cement with a revised price target of Rs 257.

Emkay said though it expects the stock to remain under pressure in the near term, the valuations are very at tractive. 2015-16 will be a challenging year for the com pany and an improvement in earnings will be a function of pricing improvement, ac cording to the brokerage.

Earnings volatility is expect ed to continue for small ce ment companies in the North region. The stock fell 4.62% to Rs 196.20 on Thursday.

ICICI Securities has retained its buy rating on Ashoka Buildcon (ABL) with a target price of Rs 240 considering the strong track record, well funded Buildoperatetrans fer (BOT) road project port folio and opportunity from awarding in the road vertical The brokerage expects ABL's construction revenues to grow at a CAGR of 16.5% to Rs 2,982.4 crore during 2014 18. The stock fell 2.36% to Rs 200.85 on Thursday.